Asymmetry Ventures

Atomic Alchemy is building scalable U.S. radioisotope production capabilities in U.S.-based facilities dedicated to producing essential isotopes for healthcare, industry, research, and defense.

BTQ delivers quantum advantage through cost-efficient solutions that create new markets and disrupt existing industries, focusing on post-quantum cryptography and quantum solutions.

Cyberdontics is revolutionizing modern dentistry through advanced imaging, AI, and robotics, helping dentists diagnose and treat patients more effectively.

CytoReason is a biotechnology company that develops AI-powered disease models to improve drug discovery and development processes.

Foresight Mental Health provides therapy and psychiatry services both online and in-person, focusing on immediate availability and a range of mental health services including child and adolescent therapy, maternal mental health, and intensive treatment services.

Frontier Bio develops advanced vascular grafts and tissue platforms for creating engineered tissues. The company focuses on building the foundation for organ-scale tissue engineering.

Genecis Bioindustries is a climate biotech company turning organic waste into sustainable, biodegradable materials, offering a circular economy solution for products’ beginning and end of life.

InpharmD™ is a digital service that provides on-demand drug information to clinical pharmacists, enabling evidence-based care through AI-powered literature searches.

Kernal Bio is a biotech company developing onco-selective mRNA therapeutics aimed at improving cancer patients' survival and quality of life. The company is engineering cells inside the body using AI-designed, selective mRNA and targeted LNP.

New Culture is revolutionizing how cheese is made with animal-free dairy products that stretch, melt, and taste like the real deal. They combine traditional cheese-making and innovative food science to create cheese that is kinder on animals, the planet, and human health.

Orbit Fab is building the in-space propellant supply chain, providing spacecraft refueling services to enable a sustainable and thriving in-space economy.

Refactor Capital is a solo GP venture fund where founders get direct access to Zal Bilimoria as the only decision-maker, applying software operator experience from Google, Netflix, and LinkedIn to hard tech sectors like aerospace, synthetic biology, and energy storage. The fund leads seed rounds with $1-2M checks targeting ~10% ownership across unusually broad hard-tech domains, backed by early hits like Solugen and Astranis.

Invests in disruptive, technology-focused startups; established in 1999.

Early-stage, first-money-in partner for technically ambitious founders transforming the physical world (energy, defense, infrastructure, space, advanced manufacturing), underwriting high technical and regulatory risk.

Early-stage investor in advanced tech and healthcare that funds companies with at least one female founder, focusing on STEM startups with female executives.